Nasdaq
DNTH
Dianthus Therapeutics, Inc.
- Health Care
- Listed 2018
- 1 day
- −2.3%
- 1 month
- +14.8%
- 1 year
- +439%
$109.92 · Mkt cap $6.15B
At the 6 Aug 2026 close
Nasdaq
Dianthus Therapeutics, Inc.
$109.92 · Mkt cap $6.15B
At the 6 Aug 2026 close
Dianthus Therapeutics, Inc. trades under the ticker DNTH on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $6.15B. The last closing price was $109.92, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +439%, and +14.8% over the past month. Returns are price returns and exclude dividends.
This page exists because DNTH is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.